Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Auditor change
Inv. presentation
Director departure

DERMA SCIENCES, INC. (DSCI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2011 BW Derma Sciences Reports Second Quarter Operating Results
06/27/2011 BW Derma Sciences Closes $29 Million Private Placement Financing
06/20/2011 BW Derma Sciences Raises $29 Million in Private Placement Financing
05/24/2011 BW Derma Sciences to Hold Conference Call Tomorrow, May 25 to Discuss 24-Week Data from Phase 2 DSC127 Trial in Diabetic Foot Ulcers
05/13/2011 BW Derma Sciences to Present at the Noble Financial Capital Markets' Seventh Annual Equity Conference
05/11/2011 BW Derma Sciences First Quarter Results Feature Positive Cash Flow from Operations, Advanced Wound Care Product Sales up 57%, Total Sales up 12%
05/06/2011 BW Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11
04/18/2011 BW Derma Sciences MEDIHONEY® and XTRASORB® Posters and Expert Presentations Featured at Symposium on Advanced Wound Care 2011
03/30/2011 BW Derma Sciences Reports Fourth Quarter Results; Sales of Advanced Wound Care Products up 59% over Prior Year; Total Net Sales New Record for Quarter
03/29/2011 BW Derma Sciences Advanced Wound Care Products Featured in Five Poster Presentations at the Diabetic Foot Global Conference 2011
03/23/2011 BW Derma Sciences Announces Fourth Quarter 2010 Financial Results Conference Call
03/08/2011 BW Derma Sciences to Present at the Roth Capital Partners Growth Stock Conference
02/28/2011 BW Derma Sciences Receives FDA Clearance for MEDIHONEY® Gel
02/22/2011 BW Department of Health and Human Services Grants $4.5 Million to Research DSC127 in Skin Injuries Associated with Acute Radiation Exposure
02/16/2011 BW Derma Sciences to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
11/16/2010 BW Derma Sciences to Present at the Fourth Annual Maxim Group Growth Conference
11/05/2010 BW Derma Sciences Announces Third Quarter 2010 Results Conference Call
09/02/2010 BW Derma Sciences Novel XTRASORB® HCS Dressings Receive Federal Reimbursement Codes; Join Foam and Classic Dressings for Complete Coverage of Product Category
08/13/2010 BW Derma Sciences Second Quarter Results Feature Net Sales Up 14%; Advanced Wound Care Sales Up 47%
08/09/2010 BW Derma Sciences Announces Second Quarter 2010 Results Conference Call
07/14/2010 PRN Webcast Alert: Derma Sciences, Inc. Announces the LHA Life Sciences & Med Tech Day 2010 Presentation
07/09/2010 BW Derma Sciences Submits 510(k) Application for MEDIHONEY Gel, Reaches Goal of 20-Person U.S. Field Sales Force

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy